Kwality Pharma

{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,751.25",
    "chg": 35.95,
    "chgp": "2.1%",
    "dir": 1,
    "prev_price": "1,715.30",
    "mcapval": "1,783.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "KPL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE552U01010",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "12.15 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "RP",
      "url": "https://www.marketsmojo.com/mojopro/strategy/3",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3982841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_mojoScore_3982841.png",
        "date": "2026-05-09 10:10:14",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3980800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_technicaldot_3980800.png",
        "date": "2026-05-08 08:04:44",
        "description": "Kwality Pharmaceuticals Ltd has demonstrated a marked shift in technical momentum, upgrading from a mildly bullish to a bullish trend across multiple timeframes. This transition is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting a positive outlook for this micro-cap pharmaceutical stock amid robust price performance relative to the broader market."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Technical Momentum Shifts Signal Renewed Investor Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-technical-momentum-shifts-signal-renewed-investor-interest-3978940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_technicaldot_3978940.png",
        "date": "2026-05-07 08:05:50",
        "description": "Kwality Pharmaceuticals Ltd has demonstrated a significant shift in price momentum and technical indicators, signalling a cautiously optimistic outlook for this micro-cap player in the Pharmaceuticals & Biotechnology sector. With a recent upgrade in its Mojo Grade from Hold to Buy and a robust 4.09% gain on the day, the stock is attracting renewed investor interest amid mixed technical signals."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3966423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KwalityPharmace_mojoScore_3966423.png",
        "date": "2026-04-28 10:10:39",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Declines 6.91%: Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-declines-691-key-events-shaping-the-week-3962435",
        "imagepath": "",
        "date": "2026-04-25 13:02:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 20:</strong> New 52-week high and all-time high reached at Rs.1,782</p>\n                    <p><strong>Apr 21:</strong> Sharp decline of 4.84% amid rising Sensex</p>\n                    <p><strong>Apr 22:</strong> Partial recovery with 3.53% gain despite Sensex dip</p>\n                    <p><strong>Apr 23:</strong> Continued rebound with 2.66% rise on weak market</p>\n                    <p><strong>Apr 24:</strong> Week closes lower at Rs.1,626.30 (-3.39%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,664.30</div></div>\n                    <div c..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1782",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1782-3953572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KwalityPharmace_priceRelatedfactors_3953572.png",
        "date": "2026-04-20 09:48:02",
        "description": "Surging past the Rs 1780 mark, Kwality Pharmaceuticals Ltd has achieved a new 52-week high on 20 Apr 2026, extending its remarkable one-year rally of 106.59% against a flat Sensex. This milestone reflects a powerful confluence of technical momentum and sustained earnings growth that has propelled the stock well above its key moving averages."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1,782 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-at-rs1782-3953498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KwalityPharmace_priceRelatedfactors_3953498.png",
        "date": "2026-04-20 09:34:34",
        "description": ""
      },
      {
        "title": "Kwality Pharmaceuticals Gains 12.48%: 3 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-gains-1248-3-key-factors-driving-the-surge-3952304",
        "imagepath": "",
        "date": "2026-04-18 13:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Stock declines 3.48% amid broader market weakness</p>\n                    <p><strong>15 Apr:</strong> Recovery begins with 3.23% gain, Sensex up 1.89%</p>\n                    <p><strong>16 Apr:</strong> Kwality Pharmaceuticals hits all-time high, surging 8.55%</p>\n                    <p><strong>17 Apr:</strong> New 52-week high at Rs.1,760, stock closes up 4.01%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,553.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1760",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1760-3950872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KwalityPharmace_priceRelatedfactors_3950872.png",
        "date": "2026-04-17 10:35:50",
        "description": "Surging past its previous peaks, Kwality Pharmaceuticals Ltd touched a new 52-week high of Rs 1760 on 17 Apr 2026, marking a remarkable rally from its 52-week low of Rs 666. This milestone caps a sustained period of price momentum, underpinned by a confluence of bullish technical indicators and steady fundamental performance."
      }
    ],
    "total": 276,
    "sid": "1002639",
    "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026",
      "datetime": "08-May-2026",
      "details": "Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "08-May-2026",
      "details": "Intimation of Revision in Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kwality Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232PB1983PLC005426</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>28.47</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gurpreet Kaur <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@kwalitypharma.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Aditya Arora <br/> Designation: Whole Time Director and CFO <br/> EmailId: aditya@kwalitypharma.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kwality Pharmaceuticals Ltd is Rated Buy

2026-05-09 10:10:14

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Kwality Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-08 08:04:44

Kwality Pharmaceuticals Ltd has demonstrated a marked shift in technical momentum, upgrading from a mildly bullish to a bullish trend across multiple timeframes. This transition is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting a positive outlook for this micro-cap pharmaceutical stock amid robust price performance relative to the broader market.

Read full news article

Kwality Pharmaceuticals Ltd Technical Momentum Shifts Signal Renewed Investor Interest

2026-05-07 08:05:50

Kwality Pharmaceuticals Ltd has demonstrated a significant shift in price momentum and technical indicators, signalling a cautiously optimistic outlook for this micro-cap player in the Pharmaceuticals & Biotechnology sector. With a recent upgrade in its Mojo Grade from Hold to Buy and a robust 4.09% gain on the day, the stock is attracting renewed investor interest amid mixed technical signals.

Read full news article

Kwality Pharmaceuticals Ltd is Rated Buy

2026-04-28 10:10:39

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Kwality Pharmaceuticals Declines 6.91%: Key Events Shaping the Week

2026-04-25 13:02:52

Key Events This Week

Apr 20: New 52-week high and all-time high reached at Rs.1,782

Apr 21: Sharp decline of 4.84% amid rising Sensex

Apr 22: Partial recovery with 3.53% gain despite Sensex dip

Apr 23: Continued rebound with 2.66% rise on weak market

Apr 24: Week closes lower at Rs.1,626.30 (-3.39%)

Week Open

Rs.1,664.30

Read full news article

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1782

2026-04-20 09:48:02

Surging past the Rs 1780 mark, Kwality Pharmaceuticals Ltd has achieved a new 52-week high on 20 Apr 2026, extending its remarkable one-year rally of 106.59% against a flat Sensex. This milestone reflects a powerful confluence of technical momentum and sustained earnings growth that has propelled the stock well above its key moving averages.

Read full news article

Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1,782 as Momentum Builds Across Timeframes

2026-04-20 09:34:34

Read full news article

Kwality Pharmaceuticals Gains 12.48%: 3 Key Factors Driving the Surge

2026-04-18 13:02:46

Key Events This Week

13 Apr: Stock declines 3.48% amid broader market weakness

15 Apr: Recovery begins with 3.23% gain, Sensex up 1.89%

16 Apr: Kwality Pharmaceuticals hits all-time high, surging 8.55%

17 Apr: New 52-week high at Rs.1,760, stock closes up 4.01%

Week Open

Rs.1,553.15

Week Close

Rs...

Read full news article

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1760

2026-04-17 10:35:50

Surging past its previous peaks, Kwality Pharmaceuticals Ltd touched a new 52-week high of Rs 1760 on 17 Apr 2026, marking a remarkable rally from its 52-week low of Rs 666. This milestone caps a sustained period of price momentum, underpinned by a confluence of bullish technical indicators and steady fundamental performance.

Read full news article

View All News